Method for quantitative determination of 1,5-anhydroglucitol
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsKazuo Aisaka, Sakae Tazoe, Katsuhiko Ando, Keiko Ochiai
Life of this patent
Estimating the term…
Loading patent…
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsKazuo Aisaka, Sakae Tazoe, Katsuhiko Ando, Keiko Ochiai
Estimating the term…
The present invention relates to a method for quantitative determination of 1,5-anhydroglucitol in a sample, which comprises mixing the sample and an enzyme having activity that is inhibited by 1,5-anhydroglucitol in a concentration-dependent manner, and measuring the activity of the enzyme; and a reagent for quantitative determination of 1,5-anhydroglucitol which comprises an enzyme having activity that is inhibited by 1,5-anhydroglucitol in a concentration-dependent manner, a substrate for the enzyme, and a reagent for quantitative determination of a product formed by the enzyme activity. The present invention also relates to novel trehalase having a Ki value of 0.33 mM or less for 1,5-anhydroglucitol; and a process for producing novel trehalase having the above-mentioned physicochemical properties, which comprises culturing in a medium a microorganism belonging to the genus Nocardia and capable of producing the trehalase, and recovering the trehalase from the culture.
A method for detecting a disease state in a mammal, comprising the steps of:
A method for the quantitative determination of 1,5-anhydroglucitol in a sample, comprising the steps of:
A method for the quantitative determination of 1,5-anhydroglucitol in a sample, comprising the steps of:
The purified enzyme trehalase which is obtained from Nocardia sp. NK-2067 (FERM BP-5359), said enzyme having:
A kit for quantitative determination of 1,5-anhydroglucitol in a sample comprising:
A kit for quantitative determination of 1,5-anhydroglucitol in a sample comprising:
A kit for quantitative determination of 1,5-anhydroglucitol in a sample comprising:
Dependencies are inferred from the claim text.